Workflow
Sensus Healthcare(SRTS)
icon
Search documents
Buying Great Under-the-Radar Stocks During the August Market Pullback
ZACKS· 2024-08-06 20:56
The stock market bounced back on Tuesday following Monday's market-wide selloff. Stocks were due for a pullback following the huge first-half rally, and the recent wave of selling has helped cool off the market. Despite the possibility of more near-term selling and volatility, the last several years highlight why investors must attempt to stay exposed to the stock market at all times. Investors who want to buy stocks in August and the rest of the summer might consider searching for stocks gaining more atten ...
Sensus Healthcare, Inc. (SRTS) Sees a More Significant Dip Than Broader Market: Some Facts to Know
ZACKS· 2024-08-01 23:15
The most recent trading session ended with Sensus Healthcare, Inc. (SRTS) standing at $6.25, reflecting a -1.88% shift from the previouse trading day's closing. The stock's change was less than the S&P 500's daily loss of 1.37%. Meanwhile, the Dow experienced a drop of 1.21%, and the technology-dominated Nasdaq saw a decrease of 2.3%. Coming into today, shares of the company had gained 25.64% in the past month. In that same time, the Medical sector gained 0.74%, while the S&P 500 gained 1.11%. The upcoming ...
Sensus Healthcare to Host Second Quarter 2024 Financial Results and Business Update Conference Call on Thursday, August 8, 2024
GlobeNewswire News Room· 2024-07-25 20:05
BOCA RATON, Fla., July 25, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and nononcological conditions, announces that management will hold a conference call on Thursday, August 8, 2024 at 4:30 p.m. Eastern time to discuss the financial results for the second quarter of 2024. In addition, management will provide a business update and a discussion on recent and upcoming milestones. Parti ...
Sensus Healthcare, Inc. (SRTS) Earnings Expected to Grow: Should You Buy?
ZACKS· 2024-07-25 15:07
Zacks Consensus Estimate Earnings Whisper For Sensus Healthcare, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +20%. So, this combination indicates that Sensus Healthcare will most likely beat the consensus EPS estimate. While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past con ...
Recent Price Trend in Sensus Healthcare (SRTS) is Your Friend, Here's Why
ZACKS· 2024-07-25 13:50
When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a trend to profit from it is easier said than done. Often, the direction of a stock's price movement reverses quickly after taking a position in it, making investors incur a short-term capital loss. So, it's important to ensure that there are enough factors -- such as sound fundamentals, positive earnings estimate re ...
Sensus Healthcare (SRTS) Upgraded to Buy: What Does It Mean for the Stock?
ZACKS· 2024-07-19 17:01
Sensus Healthcare, Inc. (SRTS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices. The power of a changing earnings picture in determining near-term stock price movements makes the Zacks rating system highly useful for individual investors, since it can be difficult to make decisions based on rating upgrades by Wall Street analysts. Thes ...
Sensus Healthcare (SRTS) Is a Great Choice for 'Trend' Investors, Here's Why
ZACKS· 2024-07-09 13:51
Often, the direction of a stock's price movement reverses quickly after taking a position in it, making investors incur a short-term capital loss. So, it's important to ensure that there are enough factors -- such as sound fundamentals, positive earnings estimate revisions, etc. -- that could keep the momentum in the stock going. Sensus Healthcare, Inc. (SRTS) is one of the several suitable candidates that passed through the screen. Here are the key reasons why it could be a profitable bet for "trend" inves ...
Sensus Healthcare, Inc. (SRTS) Stock Declines While Market Improves: Some Information for Investors
ZACKS· 2024-06-17 23:20
Analysts and investors alike will be keeping a close eye on the performance of Sensus Healthcare, Inc. in its upcoming earnings disclosure. In that report, analysts expect Sensus Healthcare, Inc. to post earnings of $0.02 per share. This would mark year-over-year growth of 200%. In the meantime, our current consensus estimate forecasts the revenue to be $6.87 million, indicating a 51.66% growth compared to the corresponding quarter of the prior year. The most recent trading session ended with Sensus Healthc ...
Sensus Healthcare, Inc. (SRTS) Stock Slides as Market Rises: Facts to Know Before You Trade
ZACKS· 2024-06-10 23:20
Sensus Healthcare, Inc. (SRTS) ended the recent trading session at $5.48, demonstrating a -0.54% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 0.26%. Elsewhere, the Dow saw an upswing of 0.18%, while the tech-heavy Nasdaq appreciated by 0.35%. Analysts and investors alike will be keeping a close eye on the performance of Sensus Healthcare, Inc. in its upcoming earnings disclosure. The company is expected to report EPS of $0.02, up 200% from the ...
Sensus Healthcare, Inc. (SRTS) Crossed Above the 20-Day Moving Average: What That Means for Investors
ZACKS· 2024-06-04 14:36
Sensus Healthcare, Inc. (SRTS) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, SRTS crossed above the 20-day moving average, suggesting a short-term bullish trend. The 20-day simple moving average is a popular investing tool. Traders like this SMA because it offers a look back at a stock's price over a shorter period and helps smooth out price fluctuations. The 20-day can also show more trend reversal signals than longer-term moving ...